Hodgson S F, Dickson E R, Eastell R, Eriksen E F, Bryant S C, Riggs B L
Division of Endocrinology, Metabolism and Internal Medicine, Mayo Clinic, Rochester, MN.
Bone. 1993 Nov-Dec;14(6):819-27. doi: 10.1016/8756-3282(93)90310-7.
Osteoporosis and fracturing are well-recognized manifestations of primary biliary cirrhosis (PBC), but the abnormalities of bone remodeling and turnover that result in bone loss are poorly understood. We used dynamic histomorphometric techniques to measure tissue level rates of cancellous bone resorption, formation, and turnover in 12 premenopausal women with PBC and in 12 normal premenopausal women. We compared these values with estimates of bone resorption and formation obtained concurrently in the same subjects by radiocalcium kinetics and biochemical markers. Rates of bone turnover were analyzed as a function of a risk score that reflects the severity of hepatic disease and cholestasis (Mayo proportional-hazards model). Positive correlations were observed between tissue level and whole skeletal estimates of bone remodeling. At the remodeling site (bone multicellular unit [BMU]), the depth of eroded lacunae was unaltered by PBC, but wall thickness was decreased. At the level of bone tissues, mean bone turnover was increased in PBC patients but varied widely and increased as hepatic disease and cholestasis worsened. We conclude that PBC causes a reduction in the volume of bone formed at the remodeling site and that the overall level of bone remodeling and turnover in PBC is strongly influenced by the severity of hepatic disease and cholestasis. We hypothesize that the rate of bone loss in PBC may be decreased by therapeutic agents that slow bone turnover, and that further bone loss may be halted by liver transplantation.
骨质疏松症和骨折是原发性胆汁性肝硬化(PBC)的公认表现,但导致骨质流失的骨重塑和骨转换异常却鲜为人知。我们采用动态组织形态计量学技术,测量了12名绝经前PBC女性患者和12名正常绝经前女性的松质骨吸收、形成和转换的组织水平速率。我们将这些值与通过放射性钙动力学和生化标志物在同一受试者中同时获得的骨吸收和形成估计值进行了比较。骨转换速率作为反映肝病和胆汁淤积严重程度的风险评分(梅奥比例风险模型)的函数进行分析。在组织水平和全骨骼骨重塑估计值之间观察到正相关。在重塑部位(骨多细胞单位[BMU]),PBC并未改变侵蚀腔隙的深度,但壁厚度减小。在骨组织水平,PBC患者的平均骨转换增加,但差异很大,并且随着肝病和胆汁淤积的加重而增加。我们得出结论,PBC导致重塑部位形成的骨量减少,并且PBC中骨重塑和转换的总体水平受肝病和胆汁淤积严重程度的强烈影响。我们推测,减缓骨转换的治疗药物可能会降低PBC中的骨质流失速率,并且肝移植可能会阻止进一步的骨质流失。